Correlation Between Rhythm Pharmaceuticals and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rhythm Pharmaceuticals and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rhythm Pharmaceuticals and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rhythm Pharmaceuticals and Larimar Therapeutics, you can compare the effects of market volatilities on Rhythm Pharmaceuticals and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rhythm Pharmaceuticals with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rhythm Pharmaceuticals and Larimar Therapeutics.
Diversification Opportunities for Rhythm Pharmaceuticals and Larimar Therapeutics
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Rhythm and Larimar is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Rhythm Pharmaceuticals and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Rhythm Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rhythm Pharmaceuticals are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Rhythm Pharmaceuticals i.e., Rhythm Pharmaceuticals and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Rhythm Pharmaceuticals and Larimar Therapeutics
Given the investment horizon of 90 days Rhythm Pharmaceuticals is expected to generate 0.66 times more return on investment than Larimar Therapeutics. However, Rhythm Pharmaceuticals is 1.53 times less risky than Larimar Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 1,760 in Rhythm Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 4,444 from holding Rhythm Pharmaceuticals or generate 252.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Rhythm Pharmaceuticals vs. Larimar Therapeutics
Performance |
Timeline |
Rhythm Pharmaceuticals |
Larimar Therapeutics |
Rhythm Pharmaceuticals and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rhythm Pharmaceuticals and Larimar Therapeutics
The main advantage of trading using opposite Rhythm Pharmaceuticals and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rhythm Pharmaceuticals position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.Rhythm Pharmaceuticals vs. Revolution Medicines | Rhythm Pharmaceuticals vs. Akero Therapeutics | Rhythm Pharmaceuticals vs. Avidity Biosciences | Rhythm Pharmaceuticals vs. Protagonist Therapeutics |
Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |